[Favorable course in carcinoma patients due to additional phenothiazine therapy].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000368:Aged; D001066:Appetite / Q000187:drug effects; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D002277:Carcinoma / Q000188:drug therapy*; D005260:Female; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D010640:Phenothiazines / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery
D010640:Phenothiazines
Günstige Verläufe bei Karzinompatienten unter zusätzlicher Behandlung mit Phenothiazinderivaten.